Skip to main content

Ensurge Micropower Signs Agreement with Leading Medical-Device Manufacturer

Written by Customer Service on . Posted in Public Companies.

SAN JOSE, Calif., October 25, 2023 — Ensurge Micropower (OSE: ENSU, and OTCQB: ENMPY) (“Ensurge” or the “Company”), today announces it has signed an agreement for its solid-state lithium microbattery technology that extends its growing roster of strategic partnership engagements into the medical-device industry. The solid-state lithium microbattery technology is being similarly evaluated by six other manufacturers and the company remains on track to enter volume production by the end of the year.

“This latest agreement with a leading Fortune 500 medical-device manufacturer opens up yet another market opportunity for our unique battery technology,” said Lars Eikeland, CEO at Ensurge. “The agreement will also demonstrate how our microbattery can help transform wearable or portable medical device design by providing a safe, reliable and more energy-dense power source that has faster charging and a more flexible form factor compared to today’s alternatives. In addition to these breakthrough capabilities and  improved cycle life, our solid-state lithium microbatteries will also be the first that can be assembled directly onto a product’s Printed Circuit Board using an industry-compatible automated Surface Mount Technology (SMT) process.”

About Ensurge Micropower
Ensurge is Energizing Innovation™ with the first ultrathin, flexible, reliable, and fundamentally safe solid-state lithium microbattery for the 1 to 100 milliampere-hour (mAh) class of wearable devices, connected sensors, and beyond. The innovative Ensurge Microbattery enables energy-dense rechargeable products that are ideal for form-factor-constrained applications including hearables (hearing aids and wireless headphones), digital and health wearables, sports and fitness devices, and IoT sensor solutions that use energy harvesting to power everyday things. The company’s state-of-the-art manufacturing facility, located in the heart of Silicon Valley, combines patented process technology and materials innovation with the scale of roll-to-roll production methods to bring the advantages of Ensurge technology to established and expanding markets.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Contact 
Investor Relations 
E-mail: IR@ensurge.com

Lars Eikeland, CEO at Ensurge 
E-mail: lars.eikeland@ensurge.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.